Genotoxic stress triggers a combined action of DNA repair and cell cycle checkpoint pathways. Protein phosphatase 2C delta (referred to as WIP1) is involved in timely inactivation of DNA damage response by suppressing function of p53 and other targets at chromatin. Here we show that WIP1 promotes DNA repair through homologous recombination. Loss or inhibition of WIP1 delayed disappearance of the ionizing radiation-induced 53BP1 foci in S/G2 cells and promoted cell death. We identify breast cancer associated protein 1 (BRCA1) as interactor and substrate of WIP1 and demonstrate that WIP1 activity is needed for correct dynamics of BRCA1 recruitment to chromatin flanking the DNA lesion. In addition, WIP1 dephosphorylates 53BP1 at Threonine 543 that was previously implicated in mediating interaction with RIF1. Finally, we report that inhibition of WIP1 allowed accumulation of DNA damage in S/G2 cells and increased sensitivity of cancer cells to a poly-(ADP-ribose) polymerase inhibitor olaparib. We propose that inhibition of WIP1 may increase sensitivity of BRCA1-proficient cancer cells to olaparib.

Cancer Cell Biology Institute of Molecular Genetics of the Czech Academy of Sciences CZ14220 Prague Czech Republic

Zobrazit více v PubMed

Hustedt N., Durocher D. The control of DNA repair by the cell cycle. Nat. Cell Biol. 2016;19:1. doi: 10.1038/ncb3452. PubMed DOI

Ferretti L., Lafranchi L., Sartori A. Controlling DNA-end resection: A new task for CDKs. Front. Genet. 2013;4:99. doi: 10.3389/fgene.2013.00099. PubMed DOI PMC

Jackson S.P., Bartek J. The DNA-damage response in human biology and disease. Nature. 2009;461:1071–1078. doi: 10.1038/nature08467. PubMed DOI PMC

Jackson Stephen P., Durocher D. Regulation of DNA Damage Responses by Ubiquitin and SUMO. Mol. Cell. 2013;49:795–807. doi: 10.1016/j.molcel.2013.01.017. PubMed DOI

Himmels S.-F., Sartori A.A. Controlling DNA-End Resection: An. Emerging Task for Ubiquitin and SUMO. Front. Genet. 2016;7:152. doi: 10.3389/fgene.2016.00152. PubMed DOI PMC

Chen H., Lisby M., Symington L.S. RPA coordinates DNA end resection and prevents formation of DNA hairpins. Mol. Cell. 2013;50:589–600. doi: 10.1016/j.molcel.2013.04.032. PubMed DOI PMC

Zou L., Elledge S.J. Sensing DNA Damage Through ATRIP Recognition of RPA-ssDNA Complexes. Science. 2003;300:1542–1548. doi: 10.1126/science.1083430. PubMed DOI

Zong D., Adam S., Wang Y., Sasanuma H., Callén E., Murga M., Chaudhuri A.R. BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation. Mol. Cell. 2019;73:1267–1281.e7. doi: 10.1016/j.molcel.2018.12.010. PubMed DOI PMC

Sy S.M.H., Huen M.S.Y., Chen J. PALB2 is an integral component of the BRCA complex required for homologous recombination repair. Proc. Natl. Acad. Sci. USA. 2009;106:7155–7160. doi: 10.1073/pnas.0811159106. PubMed DOI PMC

Zhao W., Steinfeld J.B., Liang F., Chen X., Maranon D.G., Ma C.J., Song X. BRCA1–BARD1 promotes RAD51-mediated homologous DNA pairing. Nature. 2017;550:360. doi: 10.1038/nature24060. PubMed DOI PMC

Chapman J.R., Martin R.G., Taylor J., Simon J., Boulton J. Playing the End Game: DNA Double-Strand Break Repair Pathway Choice. Mol. Cell. 2012;47:497–510. doi: 10.1016/j.molcel.2012.07.029. PubMed DOI

Panier S., Boulton S.J. Double-strand break repair: 53BP1 comes into focus. Nat. Rev. Mol. Cell Biol. 2013;15:7. doi: 10.1038/nrm3719. PubMed DOI

Sobhian B., Shao G., Lilli D.R., Culhane A.C., Moreau L.A., Xia B., Greenberg R.A. RAP80 Targets BRCA1 to Specific Ubiquitin Structures at DNA Damage Sites. Science. 2007;316:1198–1202. doi: 10.1126/science.1139516. PubMed DOI PMC

Nakamura K., Saredi G., Becker J.R., Foster B.M., Nguyen N.V., Beyer T.E., Chapman J.R. H4K20me0 recognition by BRCA1–BARD1 directs homologous recombination to sister chromatids. Nat. Cell Biol. 2019;21:311–318. doi: 10.1038/s41556-019-0282-9. PubMed DOI PMC

Fradet-Turcotte A., Canny M.D., Escribano-Díaz C., Orthwein A., Leung C.C., Huang H., Durocher D. 53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin mark. Nature. 2013;499:50–54. doi: 10.1038/nature12318. PubMed DOI PMC

Pei H., Zhang L., Luo K., Qin Y., Chesi M., Fei F., Lou Z. MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites. Nature. 2011;470:124–128. doi: 10.1038/nature09658. PubMed DOI PMC

Kleiner R.E., Verma P., Molloy K.R., Chait B.T., Kapoor T.M. Chemical proteomics reveals a γH2AX-53BP1 interaction in the DNA damage response. Nat. Chem. Biol. 2015;11:807. doi: 10.1038/nchembio.1908. PubMed DOI PMC

Callen E., di Virgilio M., Kruhlak M.J., Nieto-Soler M., Wong N., Chen H.T., Wesemann D.R. 53BP1 Mediates Productive and Mutagenic DNA Repair through Distinct Phosphoprotein Interactions. Cell. 2013;153:1266–1280. doi: 10.1016/j.cell.2013.05.023. PubMed DOI PMC

Chapman J.R., Barral P., Vannier J.B., Borel V., Steger M., Tomas-Loba A., Boulton S.J. RIF1 Is Essential for 53BP1-Dependent Nonhomologous End Joining and Suppression of DNA Double-Strand Break Resection. Mol. Cell. 2013;49:858–871. doi: 10.1016/j.molcel.2013.01.002. PubMed DOI PMC

Escribano-Díaz C., Orthwein A., Fradet-Turcotte A., Xing M., Young J.T., Tkáč J., Xu D. A Cell Cycle-Dependent Regulatory Circuit Composed of 53BP1-RIF1 and BRCA1-CtIP Controls DNA Repair Pathway Choice. Mol. Cell. 2013;49:872–883. doi: 10.1016/j.molcel.2013.01.001. PubMed DOI

Isono M., Niimi A., Oike T., Hagiwara Y., Sato H., Sekine R., Petricci E. BRCA1 Directs the Repair Pathway to Homologous Recombination by Promoting 53BP1 Dephosphorylation. Cell Rep. 2017;18:520–532. doi: 10.1016/j.celrep.2016.12.042. PubMed DOI

Densham R.M., Garvin A.J., Stone H.R., Strachan J., Baldock R.A., Daza-Martin M., Pearl L.H. Human BRCA1–BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection. Nat. Struct. Mol. Biol. 2016;23:647. doi: 10.1038/nsmb.3236. PubMed DOI PMC

Lord C.J., Ashworth A. The DNA damage response and cancer therapy. Nature. 2012;481:287–294. doi: 10.1038/nature10760. PubMed DOI

Lord C.J., Ashworth A. PARP inhibitors: Synthetic lethality in the clinic. Science. 2017;355:1152–1158. doi: 10.1126/science.aam7344. PubMed DOI PMC

Ibrahim Y.H., García-García C., Serra V., He L., Torres-Lockhart K., Prat A., Rodríguez O. PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition. Cancer Discov. 2012;2:1036–1047. doi: 10.1158/2159-8290.CD-11-0348. PubMed DOI PMC

Gogola E., Rottenberg S., Jonkers J. Resistance to PARP Inhibitors: Lessons from Preclinical Models of BRCA-Associated Cancer. Annu. Rev. Cancer Biol. 2019;3:235–254. doi: 10.1146/annurev-cancerbio-030617-050232. DOI

Karakashev S., Zhu H., Yokoyama Y., Zhao B., Fatkhutdinov N., Kossenkov A.V., Bitler B.G. BET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian Cancer. Cell Rep. 2017;21:3398–3405. doi: 10.1016/j.celrep.2017.11.095. PubMed DOI PMC

Zhong Q., Hu Z., Li Q., Yi T., Li J., Yang H. Cyclin D1 silencing impairs DNA double strand break repair, sensitizes BRCA1 wildtype ovarian cancer cells to olaparib. Gynecol. Oncol. 2019;152:157–165. doi: 10.1016/j.ygyno.2018.10.027. PubMed DOI

Kurnit K.C., Coleman R.L., Westin S.N. Using PARP Inhibitors in the Treatment of Patients with Ovarian Cancer. Curr. Treat. Opt. Oncol. 2018;19:1. doi: 10.1007/s11864-018-0572-7. PubMed DOI PMC

Macůrek L., Lindqvist A., Voets O., Kool J., Vos H.R., Medema R.H. Wip1 phosphatase is associated with chromatin and dephosphorylates gammaH2AX to promote checkpoint inhibition. Oncogene. 2010;15:2281–2291. PubMed

Macurek L., Benada J., Müllers E., Halim V.A., Krejčíková K., Burdová K., Bartek J. Downregulation of Wip1 phosphatase modulates the cellular threshold of DNA damage signaling in mitosis. Cell Cycle. 2013;12:251–262. doi: 10.4161/cc.23057. PubMed DOI PMC

Fiscella M., Zhang H., Fan S., Sakaguchi K., Shen S., Mercer W.E., Appella E. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc. Natl. Acad. Sci. USA. 1997;94:6048–6053. doi: 10.1073/pnas.94.12.6048. PubMed DOI PMC

Lu X., Ma O., Nguyen T.A., Jones S.N., Oren M., Donehower L.A. The Wip1 Phosphatase Acts as a Gatekeeper in the p53-Mdm2 Autoregulatory Loop. Cancer Cell. 2007;12:342–354. doi: 10.1016/j.ccr.2007.08.033. PubMed DOI

Shreeram S., Demidov O.N., Hee W.K., Yamaguchi H., Onishi N., Kek C., Minami Y. Wip1 Phosphatase Modulates ATM-Dependent Signaling Pathways. Mol. Cell. 2006;23:757–764. doi: 10.1016/j.molcel.2006.07.010. PubMed DOI

Shreeram S., Demidov O.N., Hee W.K., Yamaguchi H., Onishi N., Kek C., Minami Y. ATM/Wip1 activities at chromatin control Plk1 re-activation to determine G2 checkpoint duration. EMBO J. 2017;36:2161–2176. PubMed PMC

Shaltiel I.A., Aprelia M., Saurin A.T., Chowdhury D., Kops G.J., Voest E.E., Medema R.H. Distinct phosphatases antagonize the p53 response in different phases of the cell cycle. Proc. Natl. Acad. Sci. USA. 2014;111:7313–7318. doi: 10.1073/pnas.1322021111. PubMed DOI PMC

Cha H., Lowe J.M., Li H., Lee J.S., Belova G.I., Bulavin D.V., Fornace A. JWip1 Directly Dephosphorylates γ-H2AX and Attenuates the DNA Damage Response. Cancer Res. 2010;70:4112–4122. doi: 10.1158/0008-5472.CAN-09-4244. PubMed DOI PMC

Bulavin D.V., Demidov O.N., Saito S.I., Kauraniemi P., Phillips C., Amundson S.A., Kallioniemi A. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat. Genet. 2002;31:210. doi: 10.1038/ng894. PubMed DOI

Tan D.S., Lambros M.B., Rayter S., Natrajan R., Vatcheva R., Gao Q., Fenwick K. PPM1D Is a Potential Therapeutic Target in Ovarian Clear Cell Carcinomas. Clin. Cancer Res. 2009;15:2269–2280. doi: 10.1158/1078-0432.CCR-08-2403. PubMed DOI

Castellino R.C., de Bortoli M., Lu X., Moon S.H., Nguyen T.A., Shepard M.A., Kim J.Y. Medulloblastomas overexpress the p53-inactivating oncogene WIP1/PPM1D. J. Neurooncol. 2008;86:245–256. doi: 10.1007/s11060-007-9470-8. PubMed DOI PMC

Le Guezennec X., Bulavin D.V. WIP1 phosphatase at the crossroads of cancer and aging. Trends Biochem. Sci. 2010;35:109–114. doi: 10.1016/j.tibs.2009.09.005. PubMed DOI

Gilmartin A.G., Faitg T.H., Richter M., Groy A., Seefeld M.A., Darcy M.G., Minthorn E. Allosteric Wip1 phosphatase inhibition through flap-subdomain interaction. Nat. Chem. Biol. 2014;10:181–187. doi: 10.1038/nchembio.1427. PubMed DOI

Richter M., Dayaram T., Gilmartin A.G., Ganji G., Pemmasani S.K., van der Key H., Kumar R. WIP1 Phosphatase as a Potential Therapeutic Target in Neuroblastoma. PLoS ONE. 2015;10:e0115635. PubMed PMC

Pechackova S., Burdova K., Benada J., Kleiblova P., Jenikova G., Macurek L. Inhibition of WIP1 phosphatase sensitizes breast cancer cells to genotoxic stress and to MDM2 antagonist nutlin-3. Oncotarget. 2016;7:14458–14475. doi: 10.18632/oncotarget.7363. PubMed DOI PMC

Pecháčková S., Burdová K., Macurek L. WIP1 phosphatase as pharmacological target in cancer therapy. J. Mol. Med. 2017;95:589–599. doi: 10.1007/s00109-017-1536-2. PubMed DOI PMC

Stolte B., Iniguez A.B., Dharia N., Robichaud A., Conway A., Morgan A., Alexe G. Genome-scale CRISPR-Cas9 screen identifies druggable dependencies in TP53 wild-type Ewing sarcoma. J. Exp. Med. 2018;215:2137–2155. doi: 10.1084/jem.20171066. PubMed DOI PMC

Moon S.H., Lin L., Zhang X., Nguyen T.A., Darlington Y., Waldman A.S., Donehower L.A. Wildtype p53-induced phosphatase 1 dephosphorylates histone variant gamma-H2AX and suppresses DNA double strand break repair. J. Biol. Chem. 2010;285:12935–12947. doi: 10.1074/jbc.M109.071696. PubMed DOI PMC

Certo M.T., Ryu B.Y., Annis J.E., Garibov M., Jarjour J., Rawlings D.J., Scharenberg A.M. Tracking genome engineering outcome at individual DNA breakpoints. Nat. Methods. 2011;8:671. doi: 10.1038/nmeth.1648. PubMed DOI PMC

Jazayeri A., Falck J., Lukas C., Bartek J., Smith G.C., Lukas J., Jackson S.P. ATM-and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat. Cell Biol. 2006;8:37–45. doi: 10.1038/ncb1337. PubMed DOI

Gunn A., Stark J.M. I-SceI-Based Assays to Examine Distinct Repair Outcomes of Mammalian Chromosomal Double Strand Breaks. In: Bjergbæk L., editor. DNA Repair Protocols. Humana Press; Totowa, NJ, USA: 2012. pp. 379–391. PubMed

Saleh-Gohari N., Bryant H.E., Schultz N., Parker K.M., Cassel T.N., Helleday T. Spontaneous Homologous Recombination Is Induced by Collapsed Replication Forks That Are Caused by Endogenous DNA Single-Strand Breaks. Mol. Cell. Biol. 2005;25:7158–7169. doi: 10.1128/MCB.25.16.7158-7169.2005. PubMed DOI PMC

Noordermeer S.M., Adam S., Setiaputra D., Barazas M., Pettitt S.J., Ling A.K., Annunziato S. The shieldin complex mediates 53BP1-dependent DNA repair. Nature. 2018;560:117–121. doi: 10.1038/s41586-018-0340-7. PubMed DOI PMC

Schmidt C.K., Galanty Y., Sczaniecka-Clift M., Coates J., Jhujh S., Demir M., Jackson S.P. Systematic E2 screening reveals a UBE2D–RNF138–CtIP axis promoting DNA repair. Nat. Cell Biol. 2015;17:1458. doi: 10.1038/ncb3260. PubMed DOI PMC

Tibbetts R.S., Cortez D., Brumbaugh K.M., Scully R., Livingston D., Elledge S.J., Abraham R.T. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev. 2000;14:2989–3002. doi: 10.1101/gad.851000. PubMed DOI PMC

Xu B., O’Donnell A.H., Kim S.T., Kastan M.B. Phosphorylation of Serine 1387 in Brca1 Is Specifically Required for the Atm-mediated S-Phase Checkpoint after Ionizing Irradiation. Cancer Res. 2002;62:4588–4591. PubMed

Scully R., Chen J., Ochs R.L., Keegan K., Hoekstra M., Feunteun J., Livingston D.M. Dynamic Changes of BRCA1 Subnuclear Location and Phosphorylation State Are Initiated by DNA Damage. Cell. 1997;90:425–435. doi: 10.1016/S0092-8674(00)80503-6. PubMed DOI

Kim H.S., Li H., Cevher M., Parmelee A., Fonseca D., Kleiman F.E., Lee S.B. DNA Damage–Induced BARD1 Phosphorylation Is Critical for the Inhibition of Messenger RNA Processing by BRCA1/BARD1 Complex. Cancer Res. 2006;66:4561–4565. doi: 10.1158/0008-5472.CAN-05-3629. PubMed DOI

Filipponi D., Muller J., Emelyanov A., Bulavin D.V. Wip1 Controls Global Heterochromatin Silencing via ATM/BRCA1-Dependent DNA Methylation. Cancer Cell. 2013;24:528–541. doi: 10.1016/j.ccr.2013.08.022. PubMed DOI

Chowdhury D., Xu X., Zhong X., Ahmed F., Zhong J., Liao J., Lieberman J. A PP4-phosphatase complex dephosphorylates gamma-H2AX generated during DNA replication. Mol. Cell. 2008;31:33–46. doi: 10.1016/j.molcel.2008.05.016. PubMed DOI PMC

Lee D.H., Goodarzi A.A., Adelmant G.O., Pan Y., Jeggo P.A., Marto J.A., Chowdhury D. Phosphoproteomic analysis reveals that PP4 dephosphorylates KAP-1 impacting the DNA damage response. EMBO J. 2012;31:2403–2415. doi: 10.1038/emboj.2012.86. PubMed DOI PMC

Penning T.D., Zhu G.D., Gong J., Thomas S., Gandhi V.B., Liu X., Fry E.H. Optimization of Phenyl-Substituted Benzimidazole Carboxamide Poly(ADP-Ribose) Polymerase Inhibitors: Identification of (S)-2-(2-Fluoro-4-(pyrrolidin-2-yl)phenyl)-1H-benzimidazole-4-carboxamide (A-966492), a Highly Potent and Efficacious Inhibitor. J. Med. Chem. 2010;53:3142–3153. doi: 10.1021/jm901775y. PubMed DOI

Lindqvist A., de Bruijn M., Macurek L., Brás A., Mensinga A., Bruinsma W., Medema R. HWip1 confers G2 checkpoint recovery competence by counteracting p53-dependent transcriptional repression. EMBO J. 2009;28:3196–3206. doi: 10.1038/emboj.2009.246. PubMed DOI PMC

Lu X., Bocangel D., Nannenga B., Yamaguchi H., Appella E., Donehower L.A. The p53-Induced Oncogenic Phosphatase PPM1D Interacts with Uracil DNA Glycosylase and Suppresses Base Excision Repair. Mol. Cell. 2004;15:621–634. doi: 10.1016/j.molcel.2004.08.007. PubMed DOI

Nguyen T.A., Slattery S.D., Moon S.H., Darlington Y.F., Lu X., Donehower L.A. The oncogenic phosphatase WIP1 negatively regulates nucleotide excision repair. DNA Repair. 2010;9:813–823. doi: 10.1016/j.dnarep.2010.04.005. PubMed DOI PMC

Linke S.P., Sengupta S., Khabie N., Jeffries B.A., Buchhop S., Miska S., Yang Q. p53 Interacts with hRAD51 and hRAD54, and Directly Modulates Homologous Recombination. Cancer Res. 2003;63:2596–2605. PubMed

Arias-Lopez C., Lazaro-Trueba I., Kerr P., Lord C.J., Dexter T., Iravani M., Silva A. p53 modulates homologous recombination by transcriptional regulation of the RAD51 gene. EMBO Rep. 2006;7:219–224. doi: 10.1038/sj.embor.7400587. PubMed DOI PMC

Gatz S.A., Wiesmüller L. p53 in recombination and repair. Cell Death Differ. 2006;13:1003–1016. doi: 10.1038/sj.cdd.4401903. PubMed DOI

Sriraman A., Radovanovic M., Wienken M., Najafova Z., Li Y., Dobbelstein M. Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity. Oncotarget. 2016;7:31623–31638. doi: 10.18632/oncotarget.9302. PubMed DOI PMC

Chen Z., Wang L., Yao D., Yang T., Cao W.M., Dou J., Zhao Y. Wip1 inhibitor GSK2830371 inhibits neuroblastoma growth by inducing Chk2/p53-mediated apoptosis. Sci. Rep. 2016;6:38011. doi: 10.1038/srep38011. PubMed DOI PMC

Wu C.E., Esfandiari A., Ho Y.H., Wang N., Mahdi A.K., Aptullahoglu E., Lunec J. Targeting negative regulation of p53 by MDM2 and WIP1 as a therapeutic strategy in cutaneous melanoma. Br. J. Cancer. 2017;118:495. PubMed PMC

Kasibhatla S., Amarante-Mendes G.P., Finucane D., Brunner T., Bossy-Wetzel E., Green D.R. Staining of Suspension Cells with Hoechst 33258 to Detect. Apoptosis. Cold Spring Harb. Protoc. 2006;2006:pdb.prot4492. doi: 10.1101/pdb.prot4492. PubMed DOI

Shiotani B., Zou L. Single-Stranded DNA Orchestrates an ATM-to-ATR Switch at DNA Breaks. Mol. Cell. 2009;33:547–558. doi: 10.1016/j.molcel.2009.01.024. PubMed DOI PMC

PPM1D activity promotes cellular transformation by preventing senescence and cell death

RAD18 directs DNA double-strand break repair by homologous recombination to post-replicative chromatin

Phosphorylation of TRF2 promotes its interaction with TIN2 and regulates DNA damage response at telomeres

Truncated PPM1D Prevents Apoptosis in the Murine Thymus and Promotes Ionizing Radiation-Induced Lymphoma

Phosphorylation of PLK3 Is Controlled by Protein Phosphatase 6